HPV FOCAL Study
Objective: Evaluation of the long term protection of primary HPV testing for cervix screening in a large cohort of BC women
Projects
Cervix Check
CervixCheck is exploring options to improve cervix screening rates in the underscreened by use of a digital platform providing women the opportunity to self-collect of samples for HPV-based testing for cervix screening. Pilot project currently being rolled out in the Fraser Health region, w
Leads
Gina Ogilvie Discovering genetic susceptibility factors for breast cancer in an innovative international consortium
This project aims to discover new markers of breast cancer through an international effort focused on low-penetrance alleles that, in combination, have a high probability of explaining a large proportion of breast cancer risk.
Epigenomic markers of circulating cell-free DNA and treatment response in multiple myeloma
Multiple Myeloma (MM) is generally incurable and patients will eventually develop relapsed/refractory disease. Early relapse is associated with poor clinical outcomes and overall survival.
Deciphering the genome biology of relapsed lymphoid cancers to improve patient management – Genome Canada, CIHR, BC Cancer Foundation
As a co-investigator on this project and leader of the GE3LS research activities, Dr. Regier leads the health economics activities of the LSARP project.
Leads
Dean Regier Silent Genomes - Genome Canada, CIHR
The Silent Genomes project aims to elucidate and address the health inequities faced by Canadian Indigenous populations when accessing genomic technologies for the diagnosis of genetic diseases.
Leads
Dean Regier BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.